; (2) submit a report to the Congress on the results of such review; and (3) include in such report whether, taking into consideration the factors listed in section 201(c) of the Controlled Substances Act ( 21 U.S.C. 811(c) ), as well as any potential for medical benefits, any gaps in research, and any impacts of Federal restrictions and policy on research, marijuana should be transferred to a schedule other than schedule I (if marijuana has not been so transferred already). 7. No production quotas for marijuana grown for legitimate, scientific research Section 306 of the Controlled Substances Act ( 21 U.S.C. 826 ) is amended by adding at the end the following: (i) The Attorney General may only establish a quota for production of marijuana that is manufactured and distributed in accordance with the Medical Marijuana Research Act of 2016 that meets the changing medical, scientific, and industrial needs for marijuana (as defined by the National Institute on Drug Abuse). . 8. Article 28 of the Single Convention on Narcotic Drugs Article 28 of the Single Convention on Narcotic Drugs shall not be construed to prohibit, or impose additional restrictions upon, research involving marijuana, or the manufacture, distribution, or dispensing of marijuana, that is conducted in accordance with the Controlled Substances Act ( 21 U.S.C. 801 et seq.), this Act, and the amendments made by this Act. 9. No interference by Department of Justice The Attorney General of the United States, and any officer or employee of the Department of Justice, shall not interfere with the production, distribution, and sale of marijuana in accordance with this Act and the amendments made by this Act. 10. Definition In this Act, the term marijuana has the meaning given to the term marihuana in section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ).